|
Category :
Corporate
Headline :
Neuland Laborat - Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Re
Date:
23/04/2024 18:05
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2024, and; to recommend final dividend, if any, for the financial year ended March 31, 2024
|